APO Research
Talk to an analyst

APO RESEARCH · REPORT

Depression-MDD Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Depression-MDD Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025193 pages

Choose your research edition.

Industry ResearchDepression-MDD Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Depression-MDD Drugs Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Depression-MDD Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Depression-MDD Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Depression-MDD Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Depression-MDD Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Depression-MDD Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Depression-MDD Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Depression-MDD Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Depression-MDD Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Depression-MDD Drugs include Merck, Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, Teva Pharmaceutical Industries, Reviva Pharmaceuticals Holdings, Janssen Pharmaceuticals and H. Lundbeck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Depression-MDD Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Depression-MDD Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Depression-MDD Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Depression-MDD Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Depression-MDD Drugs Segment by Company

Merck

Eli Lilly

Pfizer

GlaxoSmithKline

AstraZeneca

Teva Pharmaceutical Industries

Reviva Pharmaceuticals Holdings

Janssen Pharmaceuticals

H. Lundbeck

Bristol-Myers Squibb

Depression-MDD Drugs Segment by Type

Selective Serotonin Reuptake Inhibitors,

Tricyclic Antidepressants

Atypical Antidepressants

Serotonin & Norepinephrine Reuptake Inhibitors

Depression-MDD Drugs Segment by Application

Online Pharmacy

Pharmacy

Hospital

Other

Depression-MDD Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Depression-MDD Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Depression-MDD Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Depression-MDD Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Depression-MDD Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Depression-MDD Drugs industry.

Chapter 3: Detailed analysis of Depression-MDD Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Depression-MDD Drugsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Depression-MDD Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Selective Serotonin Reuptake Inhibitors, Table 3. Key Players of Tricyclic Antidepressants Table 4. Key Players of Atypical Antidepressants Table 3. Key Players of Serotonin & Norepinephrine Reuptake Inhibitors Table 4. Global Depression-MDD Drugs Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Online Pharmacy Table 6. Key Players of Pharmacy Table 7. Key Players of Hospital Table 8. Key Players of Other Table 9. Global Depression-MDD Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Depression-MDD Drugs Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Depression-MDD Drugs Market Share by Region (2021-2026) Table 12. Global Depression-MDD Drugs Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Depression-MDD Drugs Market Share by Region (2027-2032) Table 14. Depression-MDD Drugs Industry Trends Table 15. Depression-MDD Drugs Industry Drivers Table 16. Depression-MDD Drugs Industry Opportunities and Challenges Table 17. Depression-MDD Drugs Industry Restraints Table 18. Global Depression-MDD Drugs Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Depression-MDD Drugs Revenue Market Share by Company (2021-2026) Table 20. Global Depression-MDD Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Depression-MDD Drugs Key Company Head Office and Area Served Table 22. Global Depression-MDD Drugs Company, Product Type & Application Table 23. Global Depression-MDD Drugs Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Depression-MDD Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Depression-MDD Drugs Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Depression-MDD Drugs Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Depression-MDD Drugs Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Depression-MDD Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Depression-MDD Drugs Revenue Market Share by Type (2027-2032) Table 31. Global Depression-MDD Drugs Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Depression-MDD Drugs Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Depression-MDD Drugs Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Depression-MDD Drugs Revenue Market Share by Application (2021-2026) Table 35. Global Depression-MDD Drugs Revenue Market Share by Application (2027-2032) Table 36. Merck Company Information Table 37. Merck Business Overview Table 38. Merck Depression-MDD Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Merck Depression-MDD Drugs Product Portfolio Table 40. Merck Recent Development Table 41. Eli Lilly Company Information Table 42. Eli Lilly Business Overview Table 43. Eli Lilly Depression-MDD Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Eli Lilly Depression-MDD Drugs Product Portfolio Table 45. Eli Lilly Recent Development Table 46. Pfizer Company Information Table 47. Pfizer Business Overview Table 48. Pfizer Depression-MDD Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Pfizer Depression-MDD Drugs Product Portfolio Table 50. Pfizer Recent Development Table 51. GlaxoSmithKline Company Information Table 52. GlaxoSmithKline Business Overview Table 53. GlaxoSmithKline Depression-MDD Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. GlaxoSmithKline Depression-MDD Drugs Product Portfolio Table 55. GlaxoSmithKline Recent Development Table 56. AstraZeneca Company Information Table 57. AstraZeneca Business Overview Table 58. AstraZeneca Depression-MDD Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. AstraZeneca Depression-MDD Drugs Product Portfolio Table 60. AstraZeneca Recent Development Table 61. Teva Pharmaceutical Industries Company Information Table 62. Teva Pharmaceutical Industries Business Overview Table 63. Teva Pharmaceutical Industries Depression-MDD Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Teva Pharmaceutical Industries Depression-MDD Drugs Product Portfolio Table 65. Teva Pharmaceutical Industries Recent Development Table 66. Reviva Pharmaceuticals Holdings Company Information Table 67. Reviva Pharmaceuticals Holdings Business Overview Table 68. Reviva Pharmaceuticals Holdings Depression-MDD Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Reviva Pharmaceuticals Holdings Depression-MDD Drugs Product Portfolio Table 70. Reviva Pharmaceuticals Holdings Recent Development Table 71. Janssen Pharmaceuticals Company Information Table 72. Janssen Pharmaceuticals Business Overview Table 73. Janssen Pharmaceuticals Depression-MDD Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Janssen Pharmaceuticals Depression-MDD Drugs Product Portfolio Table 75. Janssen Pharmaceuticals Recent Development Table 76. H. Lundbeck Company Information Table 77. H. Lundbeck Business Overview Table 78. H. Lundbeck Depression-MDD Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. H. Lundbeck Depression-MDD Drugs Product Portfolio Table 80. H. Lundbeck Recent Development Table 81. Bristol-Myers Squibb Company Information Table 82. Bristol-Myers Squibb Business Overview Table 83. Bristol-Myers Squibb Depression-MDD Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Bristol-Myers Squibb Depression-MDD Drugs Product Portfolio Table 85. Bristol-Myers Squibb Recent Development Table 86. North America Depression-MDD Drugs Market Size by Type (2021-2026) & (US$ Million) Table 87. North America Depression-MDD Drugs Market Size by Type (2027-2032) & (US$ Million) Table 88. North America Depression-MDD Drugs Market Size by Application (2021-2026) & (US$ Million) Table 89. North America Depression-MDD Drugs Market Size by Application (2027-2032) & (US$ Million) Table 90. North America Depression-MDD Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Depression-MDD Drugs Market Size by Country (2021-2026) Table 92. North America Depression-MDD Drugs Market Size by Country (2027-2032) Table 93. Europe Depression-MDD Drugs Market Size by Type (2021-2026) & (US$ Million) Table 94. Europe Depression-MDD Drugs Market Size by Type (2027-2032) & (US$ Million) Table 95. Europe Depression-MDD Drugs Market Size by Application (2021-2026) & (US$ Million) Table 96. Europe Depression-MDD Drugs Market Size by Application (2027-2032) & (US$ Million) Table 97. Europe Depression-MDD Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Depression-MDD Drugs Market Size by Country (2021-2026) Table 99. Europe Depression-MDD Drugs Market Size by Country (2027-2032) Table 100. China Depression-MDD Drugs Market Size by Type (2021-2026) & (US$ Million) Table 101. China Depression-MDD Drugs Market Size by Type (2027-2032) & (US$ Million) Table 102. China Depression-MDD Drugs Market Size by Application (2021-2026) & (US$ Million) Table 103. China Depression-MDD Drugs Market Size by Application (2027-2032) & (US$ Million) Table 104. Asia Depression-MDD Drugs Market Size by Type (2021-2026) & (US$ Million) Table 105. Asia Depression-MDD Drugs Market Size by Type (2027-2032) & (US$ Million) Table 106. Asia Depression-MDD Drugs Market Size by Application (2021-2026) & (US$ Million) Table 107. Asia Depression-MDD Drugs Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia Depression-MDD Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Depression-MDD Drugs Market Size by Country (2021-2026) Table 110. Asia Depression-MDD Drugs Market Size by Country (2027-2032) Table 111. South America, Middle East & Africa Depression-MDD Drugs Market Size by Type (2021-2026) & (US$ Million) Table 112. South America, Middle East & Africa Depression-MDD Drugs Market Size by Type (2027-2032) & (US$ Million) Table 113. South America, Middle East & Africa Depression-MDD Drugs Market Size by Application (2021-2026) & (US$ Million) Table 114. South America, Middle East & Africa Depression-MDD Drugs Market Size by Application (2027-2032) & (US$ Million) Table 115. South America, Middle East & Africa Depression-MDD Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. South America, Middle East & Africa Depression-MDD Drugs Market Size by Country (2021-2026) Table 117. South America, Middle East & Africa Depression-MDD Drugs Market Size by Country (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Depression-MDD Drugs Product Image Figure 2. Global Depression-MDD Drugs Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Depression-MDD Drugs Market Share by Type: 2025 VS 2032 Figure 4. Selective Serotonin Reuptake Inhibitors, Image Figure 5. Tricyclic Antidepressants Image Figure 6. Atypical Antidepressants Image Figure 7. Serotonin & Norepinephrine Reuptake Inhibitors Image Figure 8. Global Depression-MDD Drugs Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Depression-MDD Drugs Market Share by Application: 2025 VS 2032 Figure 10. Online Pharmacy Image Figure 11. Pharmacy Image Figure 12. Hospital Image Figure 13. Other Image Figure 14. Global Depression-MDD Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 16. Global Depression-MDD Drugs Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Depression-MDD Drugs Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Depression-MDD Drugs Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Depression-MDD Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Depression-MDD Drugs Revenue Market Share by Type (2021-2032) Figure 23. Global Depression-MDD Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Depression-MDD Drugs Revenue Market Share by Application (2021-2032) Figure 25. North America Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 26. North America Depression-MDD Drugs Market Share by Type (2021-2032) Figure 27. North America Depression-MDD Drugs Market Share by Application (2021-2032) Figure 28. North America Depression-MDD Drugs Market Share by Country (2021-2032) Figure 29. United States Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 30. Canada Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 32. Europe Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 33. Europe Depression-MDD Drugs Market Share by Type (2021-2032) Figure 34. Europe Depression-MDD Drugs Market Share by Application (2021-2032) Figure 35. Europe Depression-MDD Drugs Market Share by Country (2021-2032) Figure 36. Germany Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 37. France Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 39. Italy Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 40. Russia Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 42. China Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 43. China Depression-MDD Drugs Market Share by Type (2021-2032) Figure 44. China Depression-MDD Drugs Market Share by Application (2021-2032) Figure 45. Asia Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 46. Asia Depression-MDD Drugs Market Share by Type (2021-2032) Figure 47. Asia Depression-MDD Drugs Market Share by Application (2021-2032) Figure 48. Asia Depression-MDD Drugs Market Share by Country (2021-2032) Figure 49. Japan Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 53. India Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 54. Australia Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Depression-MDD Drugs Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Depression-MDD Drugs Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Depression-MDD Drugs Market Share by Country (2021-2032) Figure 59. Brazil Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 64. UAE Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 66. Chile Depression-MDD Drugs Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Selective Serotonin Reuptake Inhibitors,
  • Tricyclic Antidepressants
  • Atypical Antidepressants
  • Serotonin & Norepinephrine Reuptake Inhibitors
Applications
  • Online Pharmacy
  • Pharmacy
  • Hospital
  • Other
Companies covered
  • Merck
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • Teva Pharmaceutical Industries
  • Reviva Pharmaceuticals Holdings
  • Janssen Pharmaceuticals
  • H. Lundbeck
  • Bristol-Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Depression-MDD Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Selective Serotonin Reuptake Inhibitors,
  5. 1.2.3 Tricyclic Antidepressants
  6. 1.2.4 Atypical Antidepressants
  7. 1.2.5 Serotonin & Norepinephrine Reuptake Inhibitors
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Depression-MDD Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Online Pharmacy
  11. 1.3.3 Pharmacy
  12. 1.3.4 Hospital
  13. 1.3.5 Other
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Depression-MDD Drugs Growth Trends by Region
  16. 1.5.1 Global Depression-MDD Drugs Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Depression-MDD Drugs Market Size by Region (2021-2026)
  18. 1.5.3 Depression-MDD Drugs Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Depression-MDD Drugs Market Dynamics
  1. 2.1 Depression-MDD Drugs Industry Trends
  2. 2.2 Depression-MDD Drugs Industry Drivers
  3. 2.3 Depression-MDD Drugs Industry Opportunities and Challenges
  4. 2.4 Depression-MDD Drugs Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Depression-MDD Drugs Revenue by Company (2021-2026)
  2. 3.2 Global Depression-MDD Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Depression-MDD Drugs Key Company Head office and Area Served
  4. 3.4 Global Depression-MDD Drugs Company, Product Type & Application
  5. 3.5 Global Depression-MDD Drugs Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Depression-MDD Drugs Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Depression-MDD Drugs Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Depression-MDD Drugs Tier 1, Tier 2, and Tier 3
4 Depression-MDD Drugs Market by Type
  1. 4.1 Global Depression-MDD Drugs Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Depression-MDD Drugs Market Size by Type (2021-2032)
  3. 4.3 Global Depression-MDD Drugs Market Size Share by Type (2021-2032)
5 Depression-MDD Drugs Market by Application
  1. 5.1 Global Depression-MDD Drugs Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Depression-MDD Drugs Market Size by Application (2021-2032)
  3. 5.3 Global Depression-MDD Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Depression-MDD Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Merck Depression-MDD Drugs Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Eli Lilly
  8. 6.2.1 Eli Lilly Company Information
  9. 6.2.2 Eli Lilly Business Overview
  10. 6.2.3 Eli Lilly Depression-MDD Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Eli Lilly Depression-MDD Drugs Product Portfolio
  12. 6.2.5 Eli Lilly Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Depression-MDD Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Pfizer Depression-MDD Drugs Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 GlaxoSmithKline
  20. 6.4.1 GlaxoSmithKline Company Information
  21. 6.4.2 GlaxoSmithKline Business Overview
  22. 6.4.3 GlaxoSmithKline Depression-MDD Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 GlaxoSmithKline Depression-MDD Drugs Product Portfolio
  24. 6.4.5 GlaxoSmithKline Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Depression-MDD Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 AstraZeneca Depression-MDD Drugs Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 Teva Pharmaceutical Industries
  32. 6.6.1 Teva Pharmaceutical Industries Company Information
  33. 6.6.2 Teva Pharmaceutical Industries Business Overview
  34. 6.6.3 Teva Pharmaceutical Industries Depression-MDD Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Teva Pharmaceutical Industries Depression-MDD Drugs Product Portfolio
  36. 6.6.5 Teva Pharmaceutical Industries Recent Developments
  37. 6.7 Reviva Pharmaceuticals Holdings
  38. 6.7.1 Reviva Pharmaceuticals Holdings Company Information
  39. 6.7.2 Reviva Pharmaceuticals Holdings Business Overview
  40. 6.7.3 Reviva Pharmaceuticals Holdings Depression-MDD Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Reviva Pharmaceuticals Holdings Depression-MDD Drugs Product Portfolio
  42. 6.7.5 Reviva Pharmaceuticals Holdings Recent Developments
  43. 6.8 Janssen Pharmaceuticals
  44. 6.8.1 Janssen Pharmaceuticals Company Information
  45. 6.8.2 Janssen Pharmaceuticals Business Overview
  46. 6.8.3 Janssen Pharmaceuticals Depression-MDD Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Janssen Pharmaceuticals Depression-MDD Drugs Product Portfolio
  48. 6.8.5 Janssen Pharmaceuticals Recent Developments
  49. 6.9 H. Lundbeck
  50. 6.9.1 H. Lundbeck Company Information
  51. 6.9.2 H. Lundbeck Business Overview
  52. 6.9.3 H. Lundbeck Depression-MDD Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 H. Lundbeck Depression-MDD Drugs Product Portfolio
  54. 6.9.5 H. Lundbeck Recent Developments
  55. 6.10 Bristol-Myers Squibb
  56. 6.10.1 Bristol-Myers Squibb Company Information
  57. 6.10.2 Bristol-Myers Squibb Business Overview
  58. 6.10.3 Bristol-Myers Squibb Depression-MDD Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Bristol-Myers Squibb Depression-MDD Drugs Product Portfolio
  60. 6.10.5 Bristol-Myers Squibb Recent Developments
7 North America
  1. 7.1 North America Depression-MDD Drugs Market Size (2021-2032)
  2. 7.2 North America Depression-MDD Drugs Market Size by Type
  3. 7.2.1 North America Depression-MDD Drugs Market Size by Type (2021-2026)
  4. 7.2.2 North America Depression-MDD Drugs Market Size by Type (2027-2032)
  5. 7.2.3 North America Depression-MDD Drugs Market Share by Type (2021-2032)
  6. 7.3 North America Depression-MDD Drugs Market Size by Application
  7. 7.3.1 North America Depression-MDD Drugs Market Size by Application (2021-2026)
  8. 7.3.2 North America Depression-MDD Drugs Market Size by Application (2027-2032)
  9. 7.3.3 North America Depression-MDD Drugs Market Share by Application (2021-2032)
  10. 7.4 North America Depression-MDD Drugs Market Size by Country
  11. 7.4.1 North America Depression-MDD Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Depression-MDD Drugs Market Size by Country (2021-2026)
  13. 7.4.3 North America Depression-MDD Drugs Market Size by Country (2027-2032)
  14. 7.4.4 North America Depression-MDD Drugs Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Depression-MDD Drugs Market Size (2021-2032)
  2. 8.2 Europe Depression-MDD Drugs Market Size by Type
  3. 8.2.1 Europe Depression-MDD Drugs Market Size by Type (2021-2026)
  4. 8.2.2 Europe Depression-MDD Drugs Market Size by Type (2027-2032)
  5. 8.2.3 Europe Depression-MDD Drugs Market Share by Type (2021-2032)
  6. 8.3 Europe Depression-MDD Drugs Market Size by Application
  7. 8.3.1 Europe Depression-MDD Drugs Market Size by Application (2021-2026)
  8. 8.3.2 Europe Depression-MDD Drugs Market Size by Application (2027-2032)
  9. 8.3.3 Europe Depression-MDD Drugs Market Share by Application (2021-2032)
  10. 8.4 Europe Depression-MDD Drugs Market Size by Country
  11. 8.4.1 Europe Depression-MDD Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Depression-MDD Drugs Market Size by Country (2021-2026)
  13. 8.4.3 Europe Depression-MDD Drugs Market Size by Country (2027-2032)
  14. 8.4.4 Europe Depression-MDD Drugs Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Depression-MDD Drugs Market Size (2021-2032)
  2. 9.2 China Depression-MDD Drugs Market Size by Type
  3. 9.2.1 China Depression-MDD Drugs Market Size by Type (2021-2026)
  4. 9.2.2 China Depression-MDD Drugs Market Size by Type (2027-2032)
  5. 9.2.3 China Depression-MDD Drugs Market Share by Type (2021-2032)
  6. 9.3 China Depression-MDD Drugs Market Size by Application
  7. 9.3.1 China Depression-MDD Drugs Market Size by Application (2021-2026)
  8. 9.3.2 China Depression-MDD Drugs Market Size by Application (2027-2032)
  9. 9.3.3 China Depression-MDD Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Depression-MDD Drugs Market Size (2021-2032)
  2. 10.2 Asia Depression-MDD Drugs Market Size by Type
  3. 10.2.1 Asia Depression-MDD Drugs Market Size by Type (2021-2026)
  4. 10.2.2 Asia Depression-MDD Drugs Market Size by Type (2027-2032)
  5. 10.2.3 Asia Depression-MDD Drugs Market Share by Type (2021-2032)
  6. 10.3 Asia Depression-MDD Drugs Market Size by Application
  7. 10.3.1 Asia Depression-MDD Drugs Market Size by Application (2021-2026)
  8. 10.3.2 Asia Depression-MDD Drugs Market Size by Application (2027-2032)
  9. 10.3.3 Asia Depression-MDD Drugs Market Share by Application (2021-2032)
  10. 10.4 Asia Depression-MDD Drugs Market Size by Country
  11. 10.4.1 Asia Depression-MDD Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Depression-MDD Drugs Market Size by Country (2021-2026)
  13. 10.4.3 Asia Depression-MDD Drugs Market Size by Country (2027-2032)
  14. 10.4.4 Asia Depression-MDD Drugs Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Depression-MDD Drugs Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Depression-MDD Drugs Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Depression-MDD Drugs Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Depression-MDD Drugs Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Depression-MDD Drugs Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Depression-MDD Drugs Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Depression-MDD Drugs Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Depression-MDD Drugs Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Depression-MDD Drugs Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Depression-MDD Drugs Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Depression-MDD Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Depression-MDD Drugs Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Depression-MDD Drugs Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Depression-MDD Drugs Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst